NORTHERN TRUST CORP - XENON PHARMACEUTICALS INC ownership

XENON PHARMACEUTICALS INC's ticker is XENE and the CUSIP is 98420N105. A total of 135 filers reported holding XENON PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 10.04 and the average weighting 0.4%.

Quarter-by-quarter ownership
NORTHERN TRUST CORP ownership history of XENON PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$2,362,744
-6.3%
69,167
+5.6%
0.00%
Q2 2023$2,521,097
+15.5%
65,483
+7.3%
0.00%
Q1 2023$2,183,298
-8.0%
61,003
+1.3%
0.00%
Q4 2022$2,374,356
+29.3%
60,217
+18.3%
0.00%
Q3 2022$1,837,000
+25.8%
50,891
+6.0%
0.00%
Q2 2022$1,460,000
+6.7%
47,996
+7.2%
0.00%
Q1 2022$1,368,000
-13.4%
44,776
-11.5%
0.00%
Q4 2021$1,580,000
+172.9%
50,596
+33.7%
0.00%
Q3 2021$579,000
-30.4%
37,850
-15.4%
0.00%
Q2 2021$832,000
-8.0%
44,721
-11.6%
0.00%
Q1 2021$904,000
+26.1%
50,562
+8.5%
0.00%
Q4 2020$717,000
+3.9%
46,622
-25.2%
0.00%
Q3 2020$690,000
-10.6%
62,353
+1.2%
0.00%
Q2 2020$772,000
+16.3%
61,635
+5.2%
0.00%
Q1 2020$664,000
+14.7%
58,599
+32.7%
0.00%
Q4 2019$579,000
+70.8%
44,143
+17.3%
0.00%
Q3 2019$339,000
-8.6%
37,6360.0%0.00%
Q2 2019$371,000
+50.8%
37,636
+55.5%
0.00%
Q1 2019$246,000
+219.5%
24,202
+97.6%
0.00%
Q4 2018$77,000
-43.4%
12,246
+18.9%
0.00%
Q3 2018$136,00010,2980.00%
Other shareholders
XENON PHARMACEUTICALS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Ally Bridge Group (NY) LLC 266,961$9,119,38810.70%
COMMODORE CAPITAL LP 1,845,000$63,025,2007.37%
TLS Advisors LLC 32,956$1,1264.56%
Altium Capital Management LP 228,000$7,788,4804.06%
Paradigm Biocapital Advisors LP 1,491,835$50,961,0843.46%
GREAT POINT PARTNERS LLC 500,001$17,080,0343.11%
DAFNA Capital Management LLC 280,538$9,583,1782.98%
Nan Fung Group Holdings Ltd 106,680$3,644,1892.95%
Affinity Asset Advisors, LLC 300,438$10,262,9622.89%
Avoro Capital Advisors LLC 4,900,000$167,384,0002.61%
View complete list of XENON PHARMACEUTICALS INC shareholders